Quoin Pharmaceuticals Ltd DRC (QNRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $17.78M
Last updated: Nov 17, 2026 at 11:06 AM ET
Quoin Pharmaceuticals Ltd DRC (QNRX) Earnings: Report Dates and Results
Quoin Pharmaceuticals Ltd DRC (QNRX) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Quoin Pharmaceuticals Ltd DRC reported EPS of -$0.97, above the -$1.88 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
QNRX has an expected report date of Mar 24, 2027.
Earnings History
Of the 28 quarters below that had an estimate, QNRX beat 17 and missed 11. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 605.58% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.97 | -$1.88 | -$2.05 - -$1.47 | +48.40% | Beat | N/A | 2 | 0 up, 1 down | Nov 5, 2026 |
| Jun 30, 2026 | -$1.90 | -$1.83 | -$1.93 - -$1.61 | -3.83% | Miss | N/A | 2 | 0 up, 0 down | Aug 14, 2026 |
| Mar 31, 2026 | -$1.77 | -$2.26 | -$2.26 - -$2.26 | +21.68% | Beat | N/A | 1 | 0 up, 0 down | May 7, 2026 |
| Dec 31, 2025 | -$1.74 | -$4.02 | -$6.42 - -$1.62 | +56.72% | Beat | N/A | 2 | N/A | Mar 26, 2026 |
| Sep 30, 2025 | -$6.70 | -$1.92 | -$1.92 - -$1.92 | -248.96% | Miss | N/A | 1 | 1 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$6.28 | -$6.83 | N/A | +8.05% | Beat | N/A | 1 | 1 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$6.50 | -$4.20 | -$4.20 - -$4.20 | -54.76% | Miss | N/A | 1 | 1 up, 0 down | May 13, 2025 |
| Dec 31, 2024 | -$0.28 | -$0.43 | -$0.43 - -$0.43 | +35.33% | Beat | N/A | 1 | 0 up, 1 down | Mar 13, 2025 |
| Sep 30, 2024 | -$16.51 | -$13.99 | N/A | -18.05% | Miss | N/A | 3 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$13.67 | -$20.30 | -$26.22 - -$17.48 | +32.66% | Beat | N/A | 3 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$38.62 | -$14.35 | -$38.81 - -$14.34 | -169.13% | Miss | N/A | 2 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$2.08 | -$2.31 | -$2.37 - -$2.26 | +9.96% | Beat | N/A | 2 | 0 up, 0 down | Mar 13, 2024 |
| Sep 30, 2023 | -$68.25 | -$95.32 | -$119.23 - -$82.52 | +28.40% | Beat | N/A | 3 | 0 up, 0 down | Nov 8, 2023 |
| Jun 30, 2023 | -$73.48 | -$96.60 | N/A | +23.93% | Beat | N/A | 2 | 0 up, 0 down | Aug 2, 2023 |
| Mar 31, 2023 | -$144.10 | -$96.60 | N/A | -49.17% | Miss | -100.6% | 3 | 0 up, 0 down | May 8, 2023 |
| Dec 31, 2022 | -$0.41 | -$0.62 | -$0.93 - -$0.50 | +33.87% | Beat | N/A | 5 | 0 up, 0 down | Mar 8, 2023 |
| Sep 30, 2022 | -$395.26 | -$495.60 | N/A | +20.25% | Beat | N/A | N/A | N/A | Nov 10, 2022 |
| Jun 30, 2022 | -$1,360.80 | -$1,158.15 | N/A | -17.50% | Miss | N/A | N/A | N/A | Aug 18, 2022 |
| Mar 31, 2022 | $22,207.53 | -$4,392.51 | N/A | +605.58% | Beat | N/A | N/A | N/A | Apr 13, 2022 |
| Dec 31, 2021 | -$309.00 | -$0.74 | N/A | N/A | N/A | N/A | N/A | N/A | Mar 21, 2022 |
| Sep 30, 2021 | -$7,402.51 | -$1,365.00 | N/A | -442.31% | Miss | N/A | N/A | N/A | Dec 17, 2021 |
| Jun 30, 2021 | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 24, 2021 |
| Mar 31, 2021 | -$1.75 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 16, 2021 |
| Dec 31, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2021 |
| Sep 30, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 20, 2020 |
| Jun 30, 2020 | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 12, 2020 |
| Mar 31, 2020 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 3, 2020 |
| Dec 31, 2019 | -$0.89 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2020 |
| Sep 30, 2019 | -$3.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 19, 2019 |
| Jun 30, 2019 | -$2.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2019 |
| Mar 31, 2019 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 21, 2019 |
| Dec 31, 2018 | -$3.17 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 18, 2019 |
| Sep 30, 2018 | -$72.50 | -$70.00 | N/A | -3.57% | Miss | N/A | N/A | N/A | Nov 13, 2018 |
| Jun 30, 2018 | -$62.50 | -$72.50 | N/A | +13.79% | Beat | N/A | N/A | N/A | Aug 9, 2018 |
| Mar 31, 2018 | -$40.00 | -$75.00 | N/A | +46.67% | Beat | N/A | N/A | N/A | May 17, 2018 |
| Dec 31, 2017 | -$40.00 | -$77.50 | N/A | +48.39% | Beat | N/A | N/A | N/A | Mar 19, 2018 |
| Sep 30, 2017 | -$98.00 | -$75.00 | N/A | -30.67% | Miss | N/A | N/A | N/A | Nov 22, 2017 |
| Jun 30, 2017 | -$3.20 | -$2.75 | N/A | -16.36% | Miss | N/A | N/A | N/A | Aug 21, 2017 |
| Mar 31, 2017 | -$14.80 | -$55.00 | N/A | +73.09% | Beat | N/A | N/A | N/A | May 29, 2017 |
| Dec 31, 2016 | -$17.50 | -$50.00 | N/A | +65.00% | Beat | N/A | N/A | N/A | Mar 23, 2017 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$21.22, after -$69.08 the year before. It was -$27.60 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$21.22 | N/A |
| Dec 31, 2024 | -$69.08 | N/A |
| Dec 31, 2023 | -$287.91 | -101.4% |
| Dec 31, 2022 | $20,451.06 | N/A |
| Dec 31, 2021 | -$7,713.44 | N/A |
| Dec 31, 2020 | -$0.10 | N/A |
| Dec 31, 2019 | -$6.91 | N/A |
| Dec 31, 2018 | -$178.17 | N/A |
| Dec 31, 2017 | -$156.00 | N/A |
| Dec 31, 2016 | -$27.60 | N/A |
Frequently Asked Questions About QNRX
When is Quoin Pharmaceuticals Ltd DRC's next earnings date?
Quoin Pharmaceuticals Ltd DRC's next earnings report is expected for Mar 24, 2027.
Did QNRX beat earnings estimates last quarter?
Yes. Quoin Pharmaceuticals Ltd DRC reported EPS of -$0.97 for the quarter ended Sep 30, 2026, above the -$1.88 estimate, a 48.40% surprise.
What EPS do analysts expect from QNRX next quarter?
The consensus EPS estimate for Quoin Pharmaceuticals Ltd DRC for the quarter ending Dec 31, 2026 is -$1.20 from 8 analysts, with estimates from -$2.10 to -$0.64.
How often does QNRX beat earnings estimates?
Quoin Pharmaceuticals Ltd DRC beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of -17.17%.
QNRX pages: Overview, Earnings, Forecast, Financials, Competitors